Objectives This study investigates the effects on aortic stiffness and vasodilation by arotinolol and the underlying mechanisms in spontaneously hypertensive rats (SHR). Methods The vasodilations of rat aortas, renal and mesenteric arteries were evaluated by isometric force recording. Nitric oxide (NO) was measured in human aortic endothelial cells (HAECs) by fluorescent probes. Sixteen-week old SHRs were treated with metoprolol (200 mg·kg-1·d-1), arotinolol (30 mg·kg-1·d-1) for 8 weeks. Central arterial pressure (CAP) and pulse wave velocity (PWV) were evaluated via catheter pressure transducers. Collagen was assessed by immunohistochemistry and biochemistry assay, while endothelial nitric oxide synthase (eNOS) and eNOS phosphorylation (p-eNOS) of HAECs or aortas were analyzed by western blotting. Results Arotinolol relaxed vascular rings and the relaxations were attenuated by Nω-nitro-L-arginine methyl ester (L-NAME, NO synthase inhibitor) and the absence of endothelium. Furthermore, arotinolol-induced relaxations were attenuated by 4-aminopyridine (4-AP, Kv channels blocker). Arotinolol produced more nitric oxide compared to metoprolol and increased the expression of p-eNOS in HAECs. These results indicated that arotinolol-induced vasodilation involves endothelium-derived NO and Kv channels. The treatement with arotinolol in 8 weeks, but not metoprolol, markedly decreased CAP and PWV. Biochemistry assay and immunohistochemistry showed that aortic collagen depositions in the arotinolol groups were reduced compared with SHRs with metoprolol. Moreover, eNOS phosphorylation was significantly increased in aortinolol-treated SHR compared with SHRs with metoprolol. Conclusions Arotinolol improves arterial stiffness in SHR, which involved in increasing NO and decreasing collagen contents in large arteries.
References
[1]
Rath G, Balligand JL, Dessy C (2012) Vasodilatory mechanisms of beta receptor blockade. Curr Hypertens Rep 14: 310–317. doi: 10.1007/s11906-012-0278-3
[2]
Kosch M, Levers A, Lang D, Bartels V, Rahn KH, et al. (2008) A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension. Nephrol Dial Transplant 23: 2280–2285. doi: 10.1093/ndt/gfm936
[3]
Kampus P, Serg M, Kals J, Zagura M, Muda P, et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension 57: 1122–1128. doi: 10.1161/hypertensionaha.110.155507
[4]
Weber MA (2005) The role of the new beta-blockers in treating cardiovascular disease. Am J Hypertens 18: 169S–176S.
[5]
Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, et al. (2008) A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 26: 351–356. doi: 10.1097/hjh.0b013e3282f283c9
[6]
McEniery CM, Schmitt M, Qasem A, Webb DJ, Avolio AP, et al. (2004) Nebivolol increases arterial distensibility in vivo. Hypertension 44: 305–310. doi: 10.1161/01.hyp.0000137983.45556.6e
[7]
Hara Y, Sato E, Miyagishi A, Aono S, Nakatani H (1979) [Pharmacological properties of dl-2-(3′-t-butylamino-2′-hydroxypropylth？io)-4-(5′-carbamoyl-2′-thienyl)thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)]. Nihon Yakurigaku Zasshi 75: 707–720.
[8]
Miyagishi A, Nakahara H, Hara Y, Nakatani H (1983) Effects of the new beta-adrenoceptor blocking agent, S-596 on the peripheral autonomic nervous system and smooth muscles. Arch Int Pharmacodyn Ther 261: 222–237.
[9]
Chamiot-Clerc P, Renaud JF, Safar ME (2001) Pulse pressure, aortic reactivity, and endothelium dysfunction in old hypertensive rats. Hypertension 37: 313–321. doi: 10.1161/01.hyp.37.2.313
[10]
Chen QZ, Han WQ, Chen J, Zhu DL, Chen Y, et al. (2013) Anti-stiffness effect of apocynin in deoxycorticosterone acetate-salt hypertensive rats via inhibition of oxidative stress. Hypertens Res 36: 306–312. doi: 10.1038/hr.2012.170
[11]
Shen W, Tian C, Chen H, Yang Y, Zhu D, et al. (2013) Oxidative stress mediates chemerin-induced autophagy in endothelial cells. Free Radic Biol Med 55: 73–82. doi: 10.1016/j.freeradbiomed.2012.11.011
[12]
Han WQ, Wong WT, Tian XY, Huang Y, Wu LY, et al. (2010) Contributory role of endothelium and voltage-gated potassium channels in apocynin-induced vasorelaxations. J Hypertens 28: 2102–2110. doi: 10.1097/hjh.0b013e32833d0197
[13]
Neuman RE, Logan MA (1950) The determination of collagen and elastin in tissues. J Biol Chem 186: 549–556.
[14]
Xu C, Zarins CK, Pannaraj PS, Bassiouny HS, Glagov S (2000) Hypercholesterolemia superimposed by experimental hypertension induces differential distribution of collagen and elastin. Arterioscler Thromb Vasc Biol 20: 2566–2572. doi: 10.1161/01.atv.20.12.2566
[15]
Konduri GG, Bakhutashvili I, Eis A, Gauthier KM (2009) Impaired voltage gated potassium channel responses in a fetal lamb model of persistent pulmonary hypertension of the newborn. Pediatr Res 66: 289–294. doi: 10.1203/pdr.0b013e3181b1bc89
[16]
Morecroft I, Murray A, Nilsen M, Gurney AM, MacLean MR (2009) Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension. Br J Pharmacol 157: 1241–1249. doi: 10.1111/j.1476-5381.2009.00283.x
[17]
Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassegue B, et al. (2013) Nox2-Induced Production of Mitochondrial Superoxide in Angiotensin II-Mediated Endothelial Oxidative Stress and Hypertension. Antioxid Redox Signal. doi: 10.1089/ars.2012.4918
[18]
Garcia ML, Priest BT, Alonso-Galicia M, Zhou X, Felix JP, et al. (2014) Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis. J Pharmacol Exp Ther 348: 153–164. doi: 10.1124/jpet.113.208603
[19]
Vidal-Petiot E, Elvira-Matelot E, Mutig K, Soukaseum C, Baudrie V, et al. (2013) WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron. Proc Natl Acad Sci U S A 110: 14366–14371. doi: 10.1073/pnas.1304230110
[20]
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011–1053. doi: 10.1097/00004872-200306000-00001
[21]
Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, et al. (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113: 664–670. doi: 10.1161/circulationaha.105.579342
Kim JH, Bugaj LJ, Oh YJ, Bivalacqua TJ, Ryoo S, et al. (2009) Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol 107: 1249–1257. doi: 10.1152/japplphysiol.91393.2008
[24]
Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248–252. doi: 10.1161/01.hyp.0000138070.47616.9d
[25]
Paniagua OA, Bryant MB, Panza JA (2000) Transient hypertension directly impairs endothelium-dependent vasodilation of the human microvasculature. Hypertension 36: 941–944. doi: 10.1161/01.hyp.36.6.941
[26]
Wallace SM, Yasmin, McEniery CM, Maki-Petaja KM, Booth AD, et al. (2007) Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 50: 228–233. doi: 10.1161/hypertensionaha.107.089391
[27]
Guerrero E, Voces F, Ardanaz N, Montero MJ, Arevalo M, et al. (2003) Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats. J Cardiovasc Pharmacol 42: 348–355. doi: 10.1097/00005344-200309000-00005
[28]
Rezzani R, Porteri E, De Ciuceis C, Bonomini F, Rodella LF, et al. (2010) Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension 55: 1373–1380. doi: 10.1161/hypertensionaha.109.148254
[29]
Verbeke F, Van Biesen W, Honkanen E, Wikstrom B, Jensen PB, et al. (2011) Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 6: 153–159. doi: 10.2215/cjn.05120610
[30]
Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55: 1318–1327. doi: 10.1016/j.jacc.2009.10.061
[31]
Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME (2009) Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. J Am Coll Cardiol 53: 445–451. doi: 10.1016/j.jacc.2008.09.046
